EMA Authorised: Trazimera (trastuzumab) — Pfizer Europe MA EEIG

View source ↗

Summary

Authorised status for Trazimera (trastuzumab) by Pfizer Europe MA EEIG in the EMA system for use in stomach and breast neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Neoplasms
• Stomach Neoplasms

Drugs mentioned

• TRAZIMERA (TRASTUZUMAB-QYYP)

Snippet

Status: Authorised. Therapeutic area: Stomach Neoplasms;Breast Neoplasms. MAH: Pfizer Europe MA EEIG. Decision date: 08/07/2026